Connect with us

COVID-19

Pfizer Vaccine Provides ‘Insufficient Protection for Young Children’, Third Dose to be Added to Trial

Published

on

shutterstock 1788824081 scaled

Pharmaceutical giants Pfizer and BioNTech announced there is still some work to be done before they can confidently release the two-dose vaccine for young children. Reassuring that “no safety concerns were identified”, they need to modify their clinical trial for their coronavirus vaccine in young children, “after a two-dose regimen did not produce a sufficient immune response in children ages 2, 3, and 4” reports National Review.

Participants in the trial ages 2-4 will be given yet a third dose of the vaccine two months after they received their second dose. Reportedly participants ages six months to 24 months did see a sufficient immune response from the vaccine.

The coronavirus developed jointly by Pfizer with BioNTech is currently the only COVID-19 vaccine authorized in the U.S. for children ages 5 and up. Moderna and Johnson & Johnson vaccines are only authorized for Americans ages 18 years and older.

Pfizer spokeswoman Jerica Pitts said the companies will not increase the dosage for children but will see if the third dose results in insufficient immunity. The young participants were given one-tenth of the dose potency as the dose given to adults over age 18.

Kathrin Jansen, head of vaccine development at Pfizer, told investors in a call reported by the Washington Post “it is important to note that this adjustment is not anticipated to meaningfully change our expectations that we would file for emergency use authorization and conditional approvals in the second quarter of 2022.”

You may like

Continue Reading
1 Comment

1 Comment

  1. George D Gary

    December 20, 2021 at 8:34 pm

    This exspearament is wrong. They dont work. If they did. You wouldnt need multible shots. Masks dont work. Follow the real science. Were being played by the democrate party. Its not a pandemic anymore. Omicron. Is like a bad flu. Children have no worries. Less than. 1% mortality. Bird flu was 15%. We did nothing then?

Leave a Reply

Your email address will not be published. Required fields are marked *

COVID-19

CIA whistleblower: analysts given money to bury covid lab-leak theory

Published

on

wuhan china lab coronavirus

The House Select Subcommittee on the Coronavirus Pandemic sent a letter to CIA director William Burns discussing the CIA and a COVID-19 cover-up. The letter asserts that it has knowledge from a whistleblower from the CIA’s  “Covid Discovery Team” that was tasked with investigating the origins of the novel coronavirus. “New testimony from a highly credibly whistleblower” alleges that the CIA “rewarded six analysts with significant financial incentives to change their COVID-19 origins conclusion from a lab-leak to zoonosis

Apart from a “lone officer” in the group who believed the virus “originated through zoonosis,” the remaining officials agreed that, on balance of probabilities, the coronavirus was likely the result of a lab-leak.

“According to the whistleblower, at the end of its review, six of the seven members of the Team believed the intelligence and science were sufficient to make a low confidence assessment that Covid-19 originated from a laboratory in Wuhan, China,” the letter reads. “To come to the eventual public determination of uncertainty, the other six members were given a significant monetary incentive to change their position.”

In June, the agency declassified its report that the available evidence on the origins of the coronavirus suggested it “was not genetically engineered.”

 

 

You may like

Continue Reading

Trending